Shareholders' equity · 2011–2025
Ani Pharmaceuticals shareholders' equity
$541M+33.9% · FY2025
Ani Pharmaceuticals (ANIP) reported $541M in shareholders' equity for fiscal 2025, +33.9% year on year.
| Fiscal year | Shareholders' equity | Change | Filing |
|---|---|---|---|
| FY20252025-12-31 | $541M | +33.9% | Open → |
| FY20242024-12-31 | $404M | −6.7% | Open → |
| FY20232023-12-31 | $433M | +38.0% | Open → |
| FY20222022-12-31 | $314M | −6.0% | Open → |
| FY20212021-12-31 | $334M | +70.6% | Open → |
| FY20202020-12-31 | $196M | −8.0% | Open → |
| FY20192019-12-31 | $213M | +7.9% | Open → |
| FY20182018-12-31 | $197M | +12.9% | Open → |
| FY20172017-12-31 | $175M | +3.0% | Open → |
| FY20162016-12-31 | $170M | +6.0% | Open → |
| FY20152015-12-31 | $160M | +14.5% | Open → |
| FY20142014-12-31 | $140M | +241.3% | Open → |
| FY20132013-12-31 | $41.0M | +$83.7M | Open → |
| FY20122012-12-31 | −$42.7M | −$8.4M | Open → |
| FY20112011-12-31 | −$34.3M | — | Open → |
Shareholders' equity — Shareholders' equity is what remains after subtracting liabilities from assets — the accounting book value of the company, not its market value.
Every row links to its own SEC filing · Fiscal year 2025 · Data as of September 25, 2026
Shareholders' equity at companies of similar size
Cite this page
Ready-made references for the figures on this page, as published on September 25, 2026.
Wikipedia
{{cite web |title=Ani Pharmaceuticals shareholders' equity |url=https://companiesranked.com/en/company/ani-pharmaceuticals/shareholders-equity |website=CompaniesRanked |date=2026-09-25 |language=en}}APA 7
CompaniesRanked. (September 25, 2026). Ani Pharmaceuticals shareholders' equity. CompaniesRanked. https://companiesranked.com/en/company/ani-pharmaceuticals/shareholders-equityBibTeX
@misc{companiesranked-en-company-ani-pharmaceuticals-shareholders-equity-2026,
author = {{CompaniesRanked}},
title = {{Ani Pharmaceuticals shareholders' equity}},
year = {2026},
howpublished = {\url{https://companiesranked.com/en/company/ani-pharmaceuticals/shareholders-equity}},
note = {Compiled from SEC EDGAR XBRL filings; data as of 2026-09-25},
urldate = {2026-09-25}
}The filing itself
The numbers above are read from this document: 10-Q · 0001023024-26-000069 · August 7, 2026
{{cite web |title=Ani Pharmaceuticals shareholders' equity — 10-Q (0001023024-26-000069) |url=https://www.sec.gov/Archives/edgar/data/1023024/000102302426000069/anip-20260630.htm |website=SEC EDGAR |publisher=U.S. Securities and Exchange Commission |date=2026-08-07}}The figures are rebuilt with every data refresh, so the reference carries the publication date. Add your own access date if your style requires one.